144 filings
Page 2 of 8
6-K
791ff3c
9 Jan 23
BeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Rules
4:30pm
6-K
ennqhv5k g3jupmt
30 Dec 22
Current report (foreign)
4:30pm
6-K
ozmmu4qou5l1jki 979q
23 Nov 22
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4:30pm
6-K
shr5l0g9p4
29 Aug 22
Current report (foreign)
8:45am
6-K
5al3v49 ilvxi9dj
13 Jun 22
Current report (foreign)
8:30am
6-K
o7dcb93hj1vd0ls
9 Jun 22
Current report (foreign)
4:30pm
6-K
4gz5arar efq
22 Apr 22
Current report (foreign)
4:30pm
6-K
ug4 c4la2pn
11 Jan 22
BeyondSpring Announces Organizational Streamlining
4:50pm
6-K
wgqq3cw808o6um65oek5
30 Dec 21
Current report (foreign)
12:30pm
6-K
awixdgl77rtl5jl1j
27 Dec 21
Current report (foreign)
9:27am
6-K
sg3bb n91ac7b12
1 Dec 21
Current report (foreign)
8:21am
6-K
75qkuyvlzh1e0y1ff sr
10 Nov 21
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
4:05pm
6-K
v6uf 3ptalrg
21 Sep 21
Current report (foreign)
4:17pm
6-K
xx7lfwhe0oyrlot 65ts
10 Sep 21
Current report (foreign)
8:30am
6-K
nxstwq8rvukbgsk
26 Aug 21
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
7:15am
6-K
2cjwe0rs4a9huza5za38
5 Aug 21
Current report (foreign)
1:32pm
6-K
hhekwbdo k4k
4 Aug 21
Current report (foreign)
7:30am
6-K
8lz4w8m
14 Jul 21
BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney
7:45am
EFFECT
3ts9k1lywk0trq9rq
14 Jul 21
Notice of effectiveness
12:15am